10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,158 | -61,310 | -21,143 | -31,251 | -24,117 |
| Depreciation Amortization | 13,605 | 8,728 | 4,260 | 7,066 | 4,221 |
| Accounts receivable | -2,654 | 10,646 | 2,521 | -5,284 | 1,938 |
| Accounts payable and accrued liabilities | -3,307 | -2,810 | -653 | 4,901 | 2,686 |
| Other Working Capital | -10,065 | -1,624 | 6,051 | 44,764 | 38,879 |
| Other Operating Activity | 41,856 | 14,276 | 6,388 | 14,431 | 4,320 |
| Operating Cash Flow | $-87,723 | $-32,094 | $-2,576 | $34,627 | $27,927 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,327 | -14,818 | -8,079 | -42,742 | -36,186 |
| Purchase Sale Intangibles | -801 | N/A | N/A | -25 | N/A |
| Other Investing Activity | -801 | 0 | 0 | -25 | 0 |
| Investing Cash Flow | $-16,128 | $-14,818 | $-8,079 | $-42,767 | $-36,186 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 11,000 | 11,000 |
| Debt Repayment | -37,102 | -37,102 | -37,102 | N/A | N/A |
| Common Stock Issued | 498,302 | 11,334 | 3,283 | 414,590 | 415,697 |
| Other Financing Activity | 0 | 0 | 0 | -11,000 | -11,000 |
| Financing Cash Flow | $461,200 | $-25,768 | $-33,819 | $414,590 | $415,697 |
| Exchange Rate Effect | -144 | -123 | -116 | -45 | -37 |
| Beginning Cash Position | 476,493 | 476,493 | 476,493 | 70,088 | 70,088 |
| End Cash Position | 833,698 | 403,690 | 431,903 | 476,493 | 477,489 |
| Net Cash Flow | $357,205 | $-72,803 | $-44,590 | $406,405 | $407,401 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,723 | -32,094 | -2,576 | 34,627 | 27,927 |
| Capital Expenditure | -15,327 | -14,818 | -8,079 | -42,742 | -36,186 |
| Free Cash Flow | -103,050 | -46,912 | -10,655 | -8,115 | -8,259 |